In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $200.43/share. When a stock reaches the ...

This Dividend King is out of favor, and this medical device peer has just introduced an exciting new product.

If you are wondering whether Becton Dickinson is starting to look like good value, you are not alone. This article will help you frame that question clearly. The stock last closed at US$177.38, with a ...

Becton, Dickinson and Company has lagged behind the broader market over the past year, yet analysts remain somewhat optimistic about the stock’s prospects.

Shares of Becton Dickinson and Company (NYSE:BDX) are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting ...

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and ...